Table 2.
AKI according to severe COVID-19: patient characteristics.
| Authors | Males, n | Age, Years | Chronic Kidney Disease (CKD) |
|---|---|---|---|
| HUANG Chaolin et al. | 30 (73%) | 49 (41–58) | NA |
| WANG Dawei et al. | 75 (54.3%) | 56 (42–68) | 4 (2.9%) |
| XU Yonghao et al. | 29 (64.4%) | 56.7 ± 15.4 | NA |
| WAN Suxin et al. | 72 (53.3%) | 47 (36–55) | NA |
| LI Qiang et al. | 167 (51.4%) | 51 (36–64) | 4 (1.2%) |
| XU Shen et al. | 193 (54.3%) | NA | NA |
| LI Zhen et al. | 95 (49%) | 57 (46–67) | NA |
| ZHAO Wen et al. | 34 (44.2%) | 52 ± 20 | 5 (6.5%) |
| WANG Luwen et al. | 67 (57.8%) | 54 (38–69) | 5 (4.3% |
| ZHANG Guqin et al. | 108 (48.9%) | 55 (39–66) | 6 (2.7%) |
| LI Xiaochen et al. | 279 (50.9%) | 60 (48–69) | 10 (1.8%) |
| JIANG Xiufeng et al. | 27 (49.1%) | 45 (27–60) | 1 (1.8%) |
| HONG Kyung et al. | 38 (38.8%) | 55.4 ± 17.1 | NA |
| PEI Guangchang et al. | 182 (54.7%) | 56.3 ± 13.4 | NA |
| GUAN Wej et al. | 637 (58.1%) | 47 (35–58) | 8 (0.8%) |
| AGGARWAL Saraubah et al. | 12 (75%) | 67 (38–95) | 6 (37.5%) |
| HU Ling et al. | 166 (51.4%) | 61 (23–91) | 7 (2.2%) |
| CHAN Lili et al. | 1868 (57.7%) | 66.5 (55–78) | 323 (10%) |
| ZHENG Yi et al. | 23 (67.6%) | 66 (58–76) | 2 (5.9%) |
| YANG Luhuan et al. | 98 (49%) | 55 ± 17.1 | 3 (1.5%) |
| ARGENZIANO Michael et al. | 511 (60%) | 63 (50–75) | NA |
| SULEYMAN Geehan et al. | 165 (46.5%) | 61.8 ± 15.3 | 161 (45.3%) |